Isothermal Nucleic Acid Amplification Technology Market Report and Forecast 2025-2034

The global isothermal nucleic acid amplification technology market size was valued at USD 4.56 Billion in 2024, driven by the rising cases of pregnancy complications among women across the globe. The market size is anticipated to grow at a CAGR of 11.30% during the forecast period of 2025-2034 to achieve a value of USD 13.30 Billion by 2034 .

Isothermal Nucleic Acid Amplification Technology: Introduction

Isothermal amplification methods provide detection of a nucleic acid target sequence in a streamlined, exponential manner, and are not limited by the constraint of thermal cycling. Although these methods can vary considerably, they share some features in common.

Global Isothermal Nucleic Acid Amplification Technology Market Analysis

The key players are increasingly focusing on launching new products and kits, further propelling the market expansion. The increasing research and development activities are significantly aiding the isothermal nucleic acid amplification technology market growth.

According to a study, LAMP technology has been proven to be more effective in comparison with NAAT method as it can amplify target DNA rapidly and allows easy and fast detection of the target product. NAATs are routine laboratory techniques for the determination of disease agents. LAMP technology as a NAAT method allows for the amplification of target regions under isothermal conditions without the need for thermal cycling. It is a cost-effective method without the need for complicated instruments and high-cost laboratory infrastructure.

Global Isothermal Nucleic Acid Amplification Technology Market Segmentations

Global Isothermal Nucleic Acid Amplification Technology Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Market Breakup by Technology

• Helicase-dependent Amplification (HDA)
• Nicking Enzyme Amplification Reaction (NEAR)
• Loop-mediated Isothermal Amplification (LAMP)
• Strand Displacement Amplification (SDA)
• Nucleic Acid Sequence-based Amplification (NASBA)
• Transcription Mediated Amplification (TMA)
• Single Primer Isothermal Amplification (SPIA)
• Other Technologies

Market Breakup by Products

• Instruments
• Reagent

Market Breakup by Target Type

• Hospitals
• Research Organization
• Other End Users

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Isothermal Nucleic Acid Amplification Technology Market Overview

The market is witnessing significant growth driven by the rising prevalence of infectious diseases and cancer. The rising number of blood transfusion and donations, along with the increasing geriatric population across the globe, are some of the key factors which are propelling the growth of the market.

Increasing incidences of chronic diseases is also providing a crucial impetus to the market development. The rise in adoption of INAAT over PCR is due to the additional advantages it provides is further expected to propel the market growth. The high demand for low-cost and effective diagnostics procedures are also expected to add to the isothermal nucleic acid amplification technology market share. Isothermal technique is considered to be cost effective as it does not require to work on multiple temperatures and sample preparation, thus the demand for it has been rising.

North America is expected to lead the global market during the forecast period owing to the high incidence of chronic diseases. Continuous and effective technological advancement in isothermal nucleic acid amplification technology (INAAT) in the region has been propelling the market growth in the region. Moreover, the rising adoption of INAAT over conventional techniques in the region is also driving the global isothermal nucleic acid amplification technology market growth forward.

Isothermal Nucleic Acid Amplification Technology Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Becton Dickinson and Company
• Qiagen NV
• bioMerieux
• Abbot Laboratories
• General ELectric
• OptiGene Limited
• Thermo Fisher Scientific
• Genomtec
• BioSystems
• PCR Biosystems

This product will be delivered within 3-5 business days.